Azithromycin

also known as Zithromax · Azasite · AZI · AZM · azythromycin · T1225 · Azithro · Azithromycin monohydrate · +25 more

Small molecule targets APC, CYP3A4, MTOR via restoration / inhibition

Developed for: COVID-19 · HIV infectious disease · Mycobacterium avium complex disease · pneumonia · asthma · chronic obstructive pulmonary disease · Plasmodium falciparum malaria · trachoma
+138 more
· blepharitis · malaria · preterm premature rupture of the membranes · bacterial conjunctivitis · bacterial infectious disease · chronic bronchitis · yaws · chronic periodontitis · respiratory tract infectious disorder · bronchiectasis · chlamydia trachomatis infectious disease · cystic fibrosis · infectious disease · pregnancy disorder · protein-energy malnutrition · typhoid fever · acne · neonatal sepsis · periodontitis · sexually transmitted disease · tonsillitis · transplant-related bronchiolitis obliterans · bacterial vaginosis · bronchopulmonary dysplasia · childhood onset asthma · Crohn disease · diarrheal disease · dry eye syndrome · endometritis · gonorrhea · lung disorder · NAFLD1 · nutritional disorder · skin infection · blepharoconjunctivitis · bronchiolitis obliterans syndrome · cervical incompetence · cholera · cryptosporidiosis · Helicobacter pylori infectious disease · influenza · intestinal infectious disease · nutritional deficiency disease · pharyngitis · puerperal infection · pulmonary non-tuberculous mycobacterial infection · severe acute respiratory syndrome · shigellosis · sinusitis · viral pneumonia · abscess · acute chest syndrome · acute respiratory distress syndrome · anemia · atopic eczema · bronchitis · campylobacteriosis · cardiac valvular defect · cerebral toxoplasmosis · cervicitis · chronic rhinosinusitis · classic familial adenomatous polyposis · coronary artery disorder · critical illness polyneuropathy · cryptogenic organizing pneumonia · cutaneous leishmaniasis · disease of orbital part of eye adnexa · disease related to solid organ transplantation · dysentery · Ebola hemorrhagic fever · eye adnexa disorder · fatty liver disease · gastroparesis · gingivitis · heart valve disorder · hematopoietic and lymphoid cell neoplasm · idiopathic pulmonary fibrosis · inclusion conjunctivitis · infectious embryofetopathy · interstitial lung disease · keratitis · Lyme disease · maxillary sinusitis · meningococcal infection · multidrug-resistant tuberculosis · multiple sclerosis · Mycoplasma pneumoniae pneumonia · nephrotic syndrome · obesity disorder · obstetric disorder · onchocerciasis · otitis media · overactive bladder · parasitemia · Pediculus humanus capitis infestation · pelvic inflammatory disease · peptic ulcer disease · pertussis · pneumocystosis · pneumonia caused by pseudomonas aeruginosa infection · pulmonary sarcoidosis · pulmonary tuberculosis · purulent acute otitis media · respiratory failure · respiratory syncytial virus infectious disease · rheumatic fever · Rocky mountain spotted fever · sarcoidosis · Shiga toxin-associated hemolytic uremic syndrome · sickle cell disease · syphilis · type 1 diabetes mellitus · urethritis · urinary tract infection · acute asthma · acute diarrhea · bacterial pneumonia · chlamydia infectious disease · chronic asthma · coronary atherosclerosis · cystic disease of lung · dyskinesia of esophagus · eyelid disorder · infectious disease with sepsis · infective vaginitis · Mycoplasmoides infection · obsessive-compulsive disorder · pediatric acute-onset neuropsychiatric syndrome · periodontal disorder · pityriasis lichenoides · postinfectious bronchiolitis obliterans · preeclampsia · reactive arthritis · respiratory or thoracic malformation · respiratory syncytial virus bronchiolitis · scrub typhus · unexplained long-lasting fever/inflammatory syndrome · viral respiratory tract infection
Investigated by: Pfizer · National Institute of Allergy and Infectious Diseases (NIAID) · Merck Sharp & Dohme LLC · University of California, San Francisco · London School of Hygiene and Tropical Medicine · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
+476 more
· Bill and Melinda Gates Foundation · International Centre for Diarrhoeal Disease Research, Bangladesh · Laboratoires Thea · University of Alabama at Birmingham · Assistance Publique - Hôpitaux de Paris · Centers for Disease Control and Prevention · Emory University · Lihir Medical Centre · Tehran University of Medical Sciences · University of Melbourne · University of Washington · Aga Khan University · Cystic Fibrosis Foundation · Kenya Medical Research Institute · Medical University of Vienna · Sanofi · The University of Texas Health Science Center, Houston · University of Virginia · World Health Organization · Assiut University · Barcelona Institute for Global Health · Fund for Scientific Research, Flanders, Belgium · Johns Hopkins Bloomberg School of Public Health · Johns Hopkins University · KU Leuven · Murdoch Childrens Research Institute · National Eye Institute (NEI) · National Heart, Lung, and Blood Institute (NHLBI) · Papua New Guinea Institute of Medical Research · Rutgers, The State University of New Jersey · Sandoz · Teva Pharmaceuticals USA · The University of Queensland · The University of Western Australia · Thomas Jefferson University · University Hospital, Strasbourg, France · University of Copenhagen · University of Liverpool · University of North Carolina · University of North Carolina, Chapel Hill · University of Oxford · Wim Janssens · Abderrahmane Mami Hospital · Agentschap voor Innovatie door Wetenschap en Technologie · Amhara Public Health Institute · Assistance Publique Hopitaux De Marseille · Azidus Brasil · Beijing Tongren Hospital · Boston Children's Hospital · Brazilian Research In Intensive Care Network · Brigham and Women's Hospital · Centre Hospitalier Universitaire, Amiens · Centre de Recherche en Sante de Nouna, Burkina Faso · Columbia University · Duke University · EMS · Erasmus Medical Center · Eshmoun Clinical Research Center · FHI 360 · Harvard School of Public Health (HSPH) · Hospital Israelita Albert Einstein · Hospital Sirio-Libanes · Hospital do Coracao · Indiana University · Kamuzu University of Health Sciences · King Hussein Cancer Center · Liverpool School of Tropical Medicine · Maisonneuve-Rosemont Hospital · Malawi-Liverpool-Wellcome Trust Clinical Research Programme · Medicines for Malaria Venture · Monash University · Mylan Pharmaceuticals Inc · NHS Greater Glasgow and Clyde · National Department of Health of Papua New Guinea · all 482 on the full record

Regulatory milestones approvals, filings & regulatory actions · 6 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Label expansion	US (FDA)	ZMAX	—	2008-10-07	fda.gov ↗
Label expansions (4)	US (FDA)	ZITHROMAX	—	1996-11-22 – 2004-01-15	fda.gov ↗
Approved	US (FDA)	ZITHROMAX	—	1991-11-01	fda.gov ↗

Trials 384 · started per year

today

US approved 1991

199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 06 trials
Phase 0	NCT05961189	Sep 2023 → Apr 2026	—	Rutgers, The State University of New Jersey	Completed	No outcome recorded
Phase 0	NCT03090048	Apr → Aug 2021	acne	Manchanda Medical Clinic	Unknown	No outcome recorded
Phase 0	NCT04329572	Apr → May 2020	COVID-19	Azidus Brasil	Suspended	No outcome recorded
Phase 0	NCT04348474	Apr → Jun 2020	COVID-19	Azidus Brasil	Suspended	No outcome recorded
Phase 0	NCT03801252	Dec 2018 → Jun 2021	obesity disorder	University of Oklahoma	Completed	No outcome recorded
Phase 0	NCT02557958	Jan 2009 → Dec 2018	chronic obstructive pulmonary disease	NYU Langone Health	Completed	No outcome recorded
Phase 134 trials · 3 met primary
Phase 1	NCT07615842	Jun 2026 → Jun 2027 expected	—	University of Virginia	Not yet recruiting	No outcome recorded
Phase 1	NCT07320612	Mar → Aug 2025	nephrotic syndrome	University of Child Health Sciences and Children's Hospital, Lahore	Completed	No outcome recorded
Phase 1	NCT05796362	Aug 2024 → Nov 2025	infectious disease	Brigham and Women's Hospital	Completed	No outcome recorded
Phase 1	NCT07394725	Apr 2024 → Mar 2025	preterm premature rupture of the membranes	District Headquarters Teaching Hospital Sahiwal	Completed	No outcome recorded
Phase 1	NCT05966688	Aug 2023 → Jan 2024	—	Spero Therapeutics	Completed	No outcome recorded
Phase 1	NCT04590274	Nov 2020 → Dec 2021	COVID-19, severe acute respiratory syndrome	International Brain Research Foundation	Withdrawn	No outcome recorded
Phase 1	NCT03252067	Aug → Oct 2017	—	Beijing Tongren Hospital	Unknown	No outcome recorded
Phase 1	NCT03235141	Jul → Oct 2017	bacterial conjunctivitis	Beijing Tongren Hospital	Unknown	No outcome recorded
Phase 1	NCT02707042	Mar 2017 → May 2025	—	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 1	NCT02926326	Sep → Oct 2016	—	Mereo BioPharma	Completed	No outcome recorded
Phase 1	NCT02708992	Apr → Dec 2016	gonorrhea	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 1	NCT02630394	Sep 2015 → Dec 2017	acute chest syndrome, sickle cell disease	University of Mississippi Medical Center	Withdrawn	No outcome recorded
Phase 1	NCT01100060	Apr → Jun 2010	—	Pfizer	Completed	No outcome recorded
Phase 1	NCT01026064	Jun → Nov 2009	—	GlaxoSmithKline	Completed	No outcome recorded
Phase 1	NCT00879983	May → Jul 2009	—	Pfizer	Completed	No outcome recorded
Phase 1	NCT00983294	Jul → Aug 2008	—	Mutual Pharmaceutical Company, Inc.	Completed	No outcome recorded
Phase 1	NCT00821782	Jun → Sep 2006	—	Ortho-McNeil Janssen Scientific Affairs, LLC	Completed	No outcome recorded
Phase 1	NCT00830336	Oct → Nov 2005	—	Teva Pharmaceuticals USA	Completed	Met primary
Phase 1	NCT00760279	Sep 2005 → ?	bacterial infectious disease	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Completed	No outcome recorded
Phase 1	NCT00649935	May 2005	—	Mylan Pharmaceuticals Inc	Completed	No outcome recorded
Phase 1	NCT00650273	Apr → May 2005	—	Mylan Pharmaceuticals Inc	Completed	No outcome recorded
Phase 1	NCT00875966	Aug → Oct 2004	infectious disease	Sandoz	Completed	No outcome recorded
Phase 1	NCT00866216	Aug → Sep 2003	infectious disease	Sandoz	Completed	No outcome recorded
Phase 1	NCT00865670	Aug → Sep 2003	infectious disease	Sandoz	Completed	No outcome recorded
Phase 1	NCT00356772	Feb → Mar 2003	eye infectious disorder	Laboratoires Thea	Completed	No outcome recorded
Phase 1	NCT00357383	Oct 2002	bacterial conjunctivitis	Laboratoires Thea	Completed	No outcome recorded
Phase 1	NCT00834756	Sep → Oct 2002	—	Teva Pharmaceuticals USA	Completed	Met primary
Phase 1	NCT00834132	Jul → Aug 2002	—	Teva Pharmaceuticals USA	Completed	Met primary
Phase 1	NCT00356850	May → Jun 2002	bacterial conjunctivitis	Laboratoires Thea	Completed	No outcome recorded
Phase 1	NCT00357292	Mar → Apr 2002	bacterial conjunctivitis	Laboratoires Thea	Completed	No outcome recorded
Phase 1	NCT00357539	Feb → Mar 2002	bacterial conjunctivitis	Laboratoires Thea	Completed	No outcome recorded
Phase 1	NCT00000966	—	HIV infectious disease, cerebral toxoplasmosis	Pfizer	Completed	No outcome recorded
Phase 1	NCT00002344	—	HIV infectious disease, bacterial infectious disease	Pfizer	Completed	No outcome recorded
Phase 1	NCT00002139	—	HIV infectious disease, bacterial infectious disease	Pfizer	Completed	No outcome recorded

Phase 1/28 trials
Phase 1/2	NCT06199440	Jun 2022 → Mar 2023	chronic periodontitis, type 2 diabetes mellitus	King Abdulaziz University	Completed	No outcome recorded
Phase 1/2	NCT03250975	Aug 2017 → Dec 2026 expected	—	Vanderbilt University Medical Center	Active not recruiting	No outcome recorded
Phase 1/2	NCT02380625	Apr 2015 → Jan 2016	Ebola hemorrhagic fever	Clinical Research Management, Inc.	Unknown	No outcome recorded
Phase 1/2	NCT01783340	Apr → Dec 2013	Plasmodium falciparum malaria	Radboud University Medical Center	Withdrawn	No outcome recorded Stop: Business
Phase 1/2	NCT01379196	May 2011 → Nov 2014	disease of orbital part of eye adnexa	Rabin Medical Center	Withdrawn	No outcome recorded Stop: Enrollment
Phase 1/2	NCT01243008	Apr → Nov 2010	Lyme disease	University of Zurich	Completed	No outcome recorded
Phase 1/2	NCT01074554	Feb 2010 → Feb 2011	sarcoidosis	Vanderbilt University	Completed	No outcome recorded
Phase 1/2	NCT00599053	May 2007 → Jul 2009	bacterial infectious disease, respiratory tract infectious disorder	University of Alabama at Birmingham	Terminated	No outcome recorded Stop: Enrollment
Phase 267 trials · 3 met primary · 4 missed
Phase 2	NCT07485010	Apr 2027 → Apr 2031 expected	pulmonary non-tuberculous mycobacterial infection	The University of Queensland	Not yet recruiting	No outcome recorded
Phase 2	NCT07443436	Nov 2026 → Nov 2027 expected	interstitial lung disease	Assistance Publique - Hôpitaux de Paris	Not yet recruiting	No outcome recorded
Phase 2	NCT07433426	Mar 2026 → Aug 2029 expected	shigellosis	Johns Hopkins Bloomberg School of Public Health	Recruiting	No outcome recorded
Phase 2	NCT06618534	Nov 2024 → Apr 2026	meningococcal infection	Emory University	Completed	No outcome recorded
Phase 2	NCT05599347	Apr 2023 → Dec 2025 overdue	Crohn disease	Rambam Health Care Campus	Recruiting	No outcome recorded
Phase 2	NCT04353661	Nov 2021 → Jun 2023	chronic obstructive pulmonary disease	Genentech, Inc.	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT04326478	Oct 2021 → May 2025 overdue	cholera	Massachusetts General Hospital	Active not recruiting	No outcome recorded
Phase 2	NCT04186247	Aug 2021 → Dec 2023	Crohn disease	University of North Carolina, Chapel Hill	Terminated	No outcome recorded
Phase 2	NCT04954040	Feb → Oct 2021	COVID-19, acute respiratory distress syndrome	Maimónides Biomedical Research Institute of Córdoba	Unknown	No outcome recorded
Phase 2	NCT04395768	Sep 2020 → Sep 2021	COVID-19	National Institute of Integrative Medicine, Australia	Unknown	No outcome recorded
Phase 2	NCT04392128	Sep 2020	COVID-19, hematopoietic and lymphoid cell neoplasm	Institut de cancérologie Strasbourg Europe	Withdrawn	No outcome recorded
Phase 2	NCT03840057	Jul 2020 → Jun 2021	—	Waihong Chung	Unknown	No outcome recorded
Phase 2	NCT04575558	Jun → Sep 2020	COVID-19	Latin American Cooperative Oncology Group	Withdrawn	No outcome recorded
Phase 2	NCT04334512	Jun 2020 → Feb 2024	COVID-19	ProgenaBiome	Completed	No outcome recorded
Phase 2	NCT04358068	May → Jul 2020	COVID-19	National Institute of Allergy and Infectious Diseases (NIAID)	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT04374552	May → Nov 2020	COVID-19	Rutgers, The State University of New Jersey	Withdrawn	No outcome recorded
Phase 2	NCT04339426	Apr 2020 → Feb 2022	COVID-19	HonorHealth Research Institute	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT04335552	Apr → Jun 2020	COVID-19	Duke University	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT04341207	Apr 2020 → Apr 2022	—	Gustave Roussy, Cancer Campus, Grand Paris	Unknown	No outcome recorded
Phase 2	NCT04336332	Apr → Oct 2020	COVID-19	Rutgers, The State University of New Jersey	Terminated	No outcome recorded
Phase 2	NCT04458948	Mar → Aug 2020	COVID-19	University of New Mexico	Terminated	No outcome recorded
Phase 2	NCT04287049	Feb 2020 → Mar 2025	Mycobacterium avium complex disease	Johns Hopkins University	Completed	No outcome recorded
Phase 2	NCT03960970	Sep 2019	endometritis, skin infection	RWJ Barnabas Health at Jersey City Medical Center	Unknown	No outcome recorded
Phase 2	NCT04020380	Sep 2019 → Jun 2020	pulmonary sarcoidosis	Hull University Teaching Hospitals NHS Trust	Completed	No outcome recorded
Phase 2	NCT03278808	Sep 2018 → Dec 2019	malaria	U.S. Army Medical Research and Development Command	Withdrawn	No outcome recorded
Phase 2	NCT03664063	Sep → Oct 2018	filariasis, yaws	Lihir Medical Centre	Completed	Met primary
Phase 2	NCT03682640	Sep 2018 → Dec 2021	type 1 diabetes mellitus	Uppsala University	Unknown	No outcome recorded
Phase 2	NCT04179461	Mar 2018 → Oct 2019	childhood onset asthma	Children's Hospital Medical Center, Cincinnati	Completed	No outcome recorded
Phase 2	NCT03160638	Feb 2018 → May 2022	pulmonary tuberculosis	University Medical Center Groningen	Completed	No outcome recorded
Phase 2	NCT03249935	Aug 2017 → Sep 2018	chlamydia trachomatis infectious disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 2	NCT02839408	Jun 2015 → Dec 2016	chronic periodontitis	University of Chile	Unknown	No outcome recorded
Phase 2	NCT01919996	Dec 2013 → Oct 2015	pharyngitis, tonsillitis	Pfizer	Terminated	No outcome recorded
Phase 2	NCT01778634	Jul 2013 → Dec 2016	bacterial infectious disease	University of Maryland, Baltimore	Completed	No outcome recorded
Phase 2	NCT01797107	Mar 2013 → Jul 2014	eye adnexa disorder	Philadelphia Eye Associates	Withdrawn	No outcome recorded Stop: Enrollment
Phase 2	NCT01783860	Jan → Jul 2013	blepharitis	Tehran University of Medical Sciences	Completed	No outcome recorded
Phase 2	NCT01712711	Sep 2012 → Feb 2013	NAFLD1	Tehran University of Medical Sciences	Completed	No outcome recorded
Phase 2	NCT01876108	Jul 2012 → Jul 2013	fatty liver disease	Tehran University of Medical Sciences	Completed	No outcome recorded
Phase 2	NCT01921738	May 2012 → Mar 2013	chronic periodontitis	Isfahan University of Medical Sciences	Completed	No outcome recorded
Phase 2	NCT01759628	Apr 2012 → Jun 2013	NAFLD1	Tehran University of Medical Sciences	Completed	No outcome recorded
Phase 2	NCT01654549	Apr → Sep 2012	NAFLD1	Tehran University of Medical Sciences	Completed	Missed primary
Phase 2	NCT01432080	Sep 2011 → Dec 2012	bronchiolitis obliterans syndrome, cryptogenic organizing pneumonia	Maisonneuve-Rosemont Hospital	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT01374126	Jul 2011 → Nov 2012	Plasmodium falciparum malaria	Medical University of Vienna	Completed	No outcome recorded
Phase 2	NCT01307462	Jun 2011 → Sep 2014	transplant-related bronchiolitis obliterans	Stephanie Lee	Completed	Met primary
Phase 2	NCT01269658	Dec 2010 → Jun 2011	blepharitis	Merck Sharp & Dohme LLC	Terminated	No outcome recorded
Phase 2	NCT01220258	Nov 2010 → Aug 2011	blepharoconjunctivitis	Merck Sharp & Dohme LLC	Terminated	No outcome recorded
Phase 2	NCT01089608	Mar 2010 → Jun 2012	blepharitis	Laboratoires Thea	Completed	Missed primary
Phase 2	NCT00894530	May → Dec 2009	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT00892970	Apr 2009 → Jan 2010	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 2	NCT01323582	Feb 2009 → Dec 2012	gastroparesis	University of Florida	Terminated	Missed primary
Phase 2	NCT01464125	Nov 2008 → Oct 2009	malaria	Jomaa Pharma GmbH	Unknown	No outcome recorded
Phase 2	NCT00322465	Nov 2006 → Apr 2009	urethritis	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary
Phase 2	NCT00524095	Sep 2006 → Jul 2008	bronchiectasis, chronic bronchitis	University of Milan	Terminated	No outcome recorded
Phase 2	NCT00356005	Aug 2006 → Aug 2007	Plasmodium falciparum malaria	Medical University of Vienna	Completed	No outcome recorded
Phase 2	NCT00419848	Aug 2006 → Jan 2008	acne	Shahid Beheshti University of Medical Sciences	Unknown	No outcome recorded
Phase 2	NCT00282919	Mar 2006 → Feb 2008	Plasmodium falciparum malaria	Pfizer	Completed	No outcome recorded
Phase 2	NCT00232154	Nov 2005 → Jun 2006	sinusitis	Pfizer	Completed	No outcome recorded
Phase 2	NCT00181272	Sep 2005 → Jul 2006	asthma, chronic obstructive pulmonary disease	Johns Hopkins University	Terminated	No outcome recorded
Phase 2	NCT00644176	Nov 2004 → Apr 2005	—	Pfizer	Completed	No outcome recorded
Phase 2	NCT00323986	Oct 2004 → Apr 2006	chronic obstructive pulmonary disease	University of Milan	Terminated	Met primary
Phase 2	NCT00082563	Aug → Nov 2004	Plasmodium falciparum malaria	Pfizer	Terminated	No outcome recorded
Phase 2	NCT00127504	Jul 2003 → May 2004	onchocerciasis	Centers for Disease Control and Prevention	Completed	No outcome recorded
Phase 2	NCT00610623	Apr 2003 → Oct 2005	pneumonia caused by pseudomonas aeruginosa infection	Anbics Management-Services Ag	Terminated	No outcome recorded Stop: Business
Phase 2	NCT00000811	? → Nov 2001	HIV infectious disease, bacterial infectious disease, pneumocystosis	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 2	NCT00002192	—	HIV infectious disease, Mycobacterium avium complex disease	Anderson Clinical Research	Completed	No outcome recorded
Phase 2	NCT00043264	—	multiple sclerosis	National Center for Research Resources (NCRR)	Completed	No outcome recorded
Phase 2	NCT00000641	? → Dec 1994	HIV infectious disease, Mycobacterium avium complex disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 2	NCT00299208	? → Jul 2005	Plasmodium falciparum malaria	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded

Phase 2/317 trials · 1 met primary · 3 missed
Phase 2/3	NCT06223828	Apr 2024 → Jul 2026 overdue	childhood onset asthma, critical illness polyneuropathy	Johns Hopkins All Children's Hospital	Recruiting	No outcome recorded
Phase 2/3	NCT05971654	Jul → Sep 2023	—	Beni-Suef University	Unknown	No outcome recorded
Phase 2/3	NCT04964583	Jan → Aug 2021	COVID-19	Coordinación de Investigación en Salud, Mexico	Unknown	No outcome recorded
Phase 2/3	NCT04354428	Apr → Nov 2020	COVID-19	University of Washington	Terminated	No outcome recorded
Phase 2/3	NCT04341870	Apr → May 2020	COVID-19	Assistance Publique - Hôpitaux de Paris	Suspended	No outcome recorded
Phase 2/3	NCT04345861	Apr 2020 → Feb 2021	COVID-19, viral pneumonia	University Hospital, Montpellier	Terminated	No outcome recorded
Phase 2/3	NCT04349410	Apr → Sep 2020	COVID-19	The Camelot Foundation	Completed	No outcome recorded
Phase 2/3	NCT04310930	Mar 2020 → Jun 2029 expected	pulmonary non-tuberculous mycobacterial infection	The University of Queensland	Recruiting	No outcome recorded
Phase 2/3	NCT03683667	Sep 2018 → Mar 2020	campylobacteriosis, intestinal infectious disease, protein-energy malnutrition	Johns Hopkins Bloomberg School of Public Health	Completed	Missed primary
Phase 2/3	NCT03268902	Sep 2017 → Feb 2020	intestinal infectious disease, nutritional deficiency disease	Haydom Lutheran Hospital	Completed	Missed primary
Phase 2/3	NCT02176057	Aug 2014	trachoma	University of California, San Francisco	Withdrawn	No outcome recorded
Phase 2/3	NCT00677833	Jun 2008 → Sep 2010	Plasmodium falciparum malaria	Pfizer	Completed	Missed primary
Phase 2/3	NCT00682656	Jun 2008 → Dec 2011	cutaneous leishmaniasis	Ana Rabello	Terminated	No outcome recorded
Phase 2/3	NCT00084227	Jul 2004 → Jul 2005	Plasmodium falciparum malaria	Pfizer	Completed	No outcome recorded
Phase 2/3	NCT00082576	Jun 2004 → May 2006	Plasmodium falciparum malaria	Pfizer	Completed	Met primary
Phase 2/3	NCT00084240	Mar 2004 → Apr 2005	Plasmodium falciparum malaria	Pfizer	Terminated	No outcome recorded
Phase 2/3	NCT00074841	Sep 2003 → Jan 2005	Plasmodium falciparum malaria	Pfizer	Completed	No outcome recorded

Phase 3101 trials · 12 met primary · 18 missed
Phase 3	NCT06605118	Nov 2024 → Nov 2027 expected	obstetric disorder	The George Washington University Biostatistics Center	Recruiting	No outcome recorded
Phase 3	NCT05994742	Jul 2024 → Aug 2026 overdue	HIV infectious disease, protein-energy malnutrition	Queen Mary University of London	Active not recruiting	No outcome recorded
Phase 3	NCT05580666	May 2023 → Nov 2028 expected	HIV infectious disease	Population Health Research Institute	Recruiting	No outcome recorded
Phase 3	NCT05157685	Nov 2022 → Nov 2027 expected	chronic rhinosinusitis	Centre Hospitalier Intercommunal Creteil	Recruiting	No outcome recorded
Phase 3	NCT05473234	Oct 2022 → Nov 2023	protein-energy malnutrition	University of California, San Francisco	Terminated	No outcome recorded
Phase 3	NCT05398055	May 2022 → Dec 2025	Rocky mountain spotted fever	Hospital General de Mexicali	Unknown	No outcome recorded
Phase 3	NCT05026749	Feb 2022 → Jul 2027 expected	respiratory syncytial virus infectious disease	University of Alabama at Birmingham	Recruiting	No outcome recorded
Phase 3	NCT04198649	Nov 2021 → Nov 2023	chronic periodontitis	University Hospital, Strasbourg, France	Terminated	No outcome recorded
Phase 3	NCT05629468	Oct 2021 → Jun 2022	acne	Pak Emirates Military Hospital	Completed	No outcome recorded
Phase 3	NCT03871491	Sep 2020 → Sep 2022	infectious embryofetopathy, neonatal sepsis, puerperal infection	NICHD Global Network for Women's and Children's Health	Completed	Mixed
Phase 3	NCT04405921	Jul → Dec 2020	COVID-19	Centre Hôpital Universitaire Farhat Hached	Unknown	No outcome recorded
Phase 3	NCT04381962	Jun 2020 → Jan 2021	COVID-19	University of Oxford	Completed	Missed primary
Phase 3	NCT03568643	Jun → Dec 2020	—	University of California, San Francisco	Completed	No outcome recorded
Phase 3	NCT04347512	Jun 2020	COVID-19	University Hospital, Strasbourg, France	Withdrawn	No outcome recorded
Phase 3	NCT04332107	May 2020 → Mar 2021	COVID-19	Thomas M. Lietman	Terminated	Missed primary
Phase 3	NCT04528927	May → Jul 2020	COVID-19	Abderrahmane Mami Hospital	Withdrawn	No outcome recorded
Phase 3	NCT04339816	May → Nov 2020	COVID-19, respiratory failure	Frantisek Duska, MD, PhD	Terminated	No outcome recorded
Phase 3	NCT04411433	May → Dec 2020	COVID-19	Ministry of Health, Turkey	Unknown	No outcome recorded
Phase 3	NCT04365582	May → Dec 2020	COVID-19	Fondation Hôpital Saint-Joseph	Withdrawn	No outcome recorded
Phase 3	NCT04358081	May → Jul 2020	COVID-19	Novartis Pharmaceuticals	Completed	No outcome recorded
Phase 3	NCT04363060	Apr → Jul 2020	pneumonia	Nantes University Hospital	Unknown	No outcome recorded
Phase 3	NCT04361461	Apr → Nov 2020	COVID-19, lung disorder, severe acute respiratory syndrome	Apsen Farmaceutica S.A.	Withdrawn	No outcome recorded Stop: Enrollment
Phase 3	NCT04371107	Apr → Jun 2020	COVID-19	Centre Hospitalier Universitaire, Amiens	Suspended	No outcome recorded
Phase 3	NCT04359953	Apr 2020 → Apr 2022	COVID-19	University Hospital, Strasbourg, France	Terminated	No outcome recorded Stop: Enrollment
Phase 3	NCT04338698	Apr → Nov 2020	COVID-19	Shehnoor Azhar	Completed	No outcome recorded
Phase 3	NCT04530422	Apr → Jul 2020	COVID-19	Almaza Military Fever Hospital	Completed	No outcome recorded
Phase 3	NCT04344444	Apr 2020 → Apr 2021	COVID-19	LCMC Health	Terminated	No outcome recorded
Phase 3	NCT04322123	Apr → Jun 2020	COVID-19	Hospital do Coracao	Completed	Missed primary
Phase 3	NCT04365231	Apr → Jun 2020	COVID-19	Hospital St. Joseph, Marseille, France	Withdrawn	No outcome recorded
Phase 3	NCT04371406	Apr → Aug 2020	COVID-19	Assistance Publique - Hôpitaux de Paris	Withdrawn	No outcome recorded
Phase 3	NCT04321278	Mar → Jun 2020	COVID-19, viral pneumonia	Hospital Israelita Albert Einstein	Completed	Missed primary
Phase 3	NCT03925480	Jul 2019 → May 2022	bacterial infectious disease	Murdoch Childrens Research Institute	Completed	Missed primary
Phase 3	NCT03545373	Feb 2019 → Mar 2020	pneumonia, tuberculosis	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 3	NCT03676140	Oct → Dec 2018	filariasis, scabies, strongyloidiasis, trachoma +1	Lihir Medical Centre	Completed	No outcome recorded
Phase 3	NCT03208179	Mar 2018 → Mar 2020	malaria, pregnancy disorder	Liverpool School of Tropical Medicine	Completed	Missed primary
Phase 3	NCT03236987	Feb 2018 → Feb 2028 expected	Mycobacterium avium complex disease, respiratory tract infectious disorder	Centre Hospitalier Universitaire, Amiens	Recruiting	No outcome recorded
Phase 3	NCT03199547	Oct 2017 → May 2021	neonatal sepsis	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 3	NCT03130114	May 2017 → Jan 2020	diarrheal disease	World Health Organization	Completed	Mixed
Phase 3	NCT03060473	Feb 2017 → Dec 2023	preterm premature rupture of the membranes	The University of Texas Medical Branch, Galveston	Terminated	No outcome recorded
Phase 3	NCT02735707	Apr 2016 → Feb 2026 overdue	pneumonia	UMC Utrecht	Recruiting	Mixed
Phase 3	NCT02754583	Dec 2015 → Dec 2024	trachoma	University of California, San Francisco	Completed	Missed primary
Phase 3	NCT02531984	Aug 2015 → Aug 2017	bronchiectasis	Assistance Publique Hopitaux De Marseille	Unknown	No outcome recorded
Phase 3	NCT02344628	Jun 2015 → Dec 2016	yaws	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 3	NCT02282176	Jan 2015 → Jan 2017	bronchopulmonary dysplasia	French National Institute of Health and Medical Research	Withdrawn	No outcome recorded
Phase 3	NCT02205242	Sep 2014 → Apr 2018	chronic obstructive pulmonary disease	Wim Janssens	Completed	No outcome recorded
Phase 3	NCT02135354	Aug 2014 → Oct 2017	chronic obstructive pulmonary disease	Wim Janssens	Terminated	Met primary Stop: Enrollment
Phase 3	NCT02205255	Aug 2014 → Apr 2018	chronic obstructive pulmonary disease	Wim Janssens	Completed	No outcome recorded
Phase 3	NCT02211729	May 2014 → Dec 2017	malaria, respiratory tract infectious disorder	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 3	NCT01959100	Feb 2014 → Apr 2017	hematopoietic and lymphoid system neoplasm	Assistance Publique - Hôpitaux de Paris	Unknown	Missed primary
Phase 3	NCT02196493	Dec 2013 → Dec 2016	—	University of Nottingham	Unknown	No outcome recorded
Phase 3	NCT01825031	Jun 2013 → Mar 2016	HIV infectious disease	Medical Research Council	Completed	Missed primary
Phase 3	NCT01955252	Mar 2013 → May 2017	yaws	Lihir Medical Centre	Completed	No outcome recorded
Phase 3	NCT01800942	Feb 2013 → Dec 2014	neonatal sepsis	London School of Hygiene and Tropical Medicine	Completed	Met primary
Phase 3	NCT05169255	Dec 2012 → Apr 2016	—	University of California, San Diego	Completed	No outcome recorded
Phase 3	NCT01721694	Dec 2012 → Mar 2013	bacterial conjunctivitis, blepharitis, keratitis	Adapt Produtos Oftalmológicos Ltda.	Withdrawn	No outcome recorded
Phase 3	NCT02726269	Jun 2012 → Mar 2014	Helicobacter pylori infectious disease	Asofarma de México S.A de C.V.	Completed	Met primary
Phase 3	NCT01270074	Apr 2012 → Mar 2020	bronchiectasis, cystic fibrosis	The University of Queensland	Completed	Missed primary
Phase 3	NCT01408082	Oct 2011 → Mar 2013	blepharitis	Sun Pharmaceutical Industries, Inc.	Completed	No outcome recorded
Phase 3	NCT01103713	Mar 2011 → Jun 2013	parasitemia	Pfizer	Terminated	No outcome recorded
Phase 3	NCT01272635	Mar 2011 → Jan 2015	asthma	Milton S. Hershey Medical Center	Completed	Met primary
Phase 3	NCT01103063	Oct 2010 → Oct 2013	—	Pfizer	Terminated	Missed primary
Phase 3	NCT01382004	Sep 2010 → Sep 2011	yaws	Lihir Medical Centre	Completed	Met primary
Phase 3	NCT01556334	Apr 2010 → Oct 2012	preterm premature rupture of the membranes	Indiana University	Withdrawn	No outcome recorded
Phase 3	NCT01072136	Mar 2010 → Sep 2011	bacterial vaginosis, cervicitis	National Institute of Allergy and Infectious Diseases (NIAID)	Terminated	No outcome recorded
Phase 3	NCT00980148	Dec 2009 → May 2014	chlamydia trachomatis infectious disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary
Phase 3	NCT01136850	Nov 2009 → Dec 2012	anemia, malaria, sexually transmitted disease	University of Melbourne	Completed	Met primary
Phase 3	NCT01071161	Sep 2009 → Feb 2012	chronic bronchitis	Isala	Completed	Met primary
Phase 3	NCT00871494	May 2009 → Nov 2010	pelvic inflammatory disease	Pfizer	Completed	No outcome recorded
Phase 3	NCT00852579	Mar 2009 → Aug 2011	asthma	Euan J Cameron	Completed	No outcome recorded
Phase 3	NCT00809328	Feb 2009 → Mar 2010	pneumonia	Pfizer	Completed	No outcome recorded
Phase 3	NCT00694694	Jun → Dec 2008	malaria	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 3	NCT00578955	Dec 2007 → Oct 2008	blepharoconjunctivitis	Sun Pharmaceutical Industries, Inc.	Completed	No outcome recorded
Phase 3	NCT00392223	Oct 2007 → Jun 2008	acne	Pfizer	Terminated	No outcome recorded
Phase 3	NCT00379821	Feb 2007 → Aug 2009	Plasmodium falciparum malaria	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary
Phase 3	NCT00367653	Nov 2006 → Sep 2007	Plasmodium falciparum malaria	Pfizer	Completed	Met primary
Phase 3	NCT00393835	Nov 2006 → May 2007	respiratory tract infectious disorder	Pfizer	Completed	No outcome recorded
Phase 3	NCT00360464	Oct 2006 → Jun 2007	bronchitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00360295	Sep 2006 → May 2007	pneumonia	Pfizer	Completed	No outcome recorded
Phase 3	NCT00254566	Feb 2006 → Aug 2008	chronic bronchitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00315003	Jan → Jul 2006	purulent acute otitis media	Sanofi	Terminated	No outcome recorded
Phase 3	NCT00266851	Jan 2006 → Nov 2010	asthma	University of Wisconsin, Madison	Completed	Missed primary
Phase 3	NCT00140023	Sep 2005 → Jun 2006	pneumonia	Pfizer	Completed	No outcome recorded
Phase 3	NCT00105469	Jul 2004 → Oct 2005	bacterial conjunctivitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 3	NCT00105534	Jul 2004 → Jan 2006	bacterial conjunctivitis	Merck Sharp & Dohme LLC	Completed	Met primary
Phase 3	NCT00357773	May 2004 → Jun 2005	bacterial conjunctivitis	Laboratoires Thea	Completed	No outcome recorded
Phase 3	NCT00356720	Jan → May 2004	trachoma	Laboratoires Thea	Completed	No outcome recorded
Phase 3	NCT00131235	Dec 2003 → Jun 2007 overdue	malaria, sexually transmitted disease	Tampere University	Active not recruiting	Met primary
Phase 3	NCT00643149	May 2003 → Mar 2004	tonsillitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00643734	Apr 2003 → Apr 2004	pneumonia	Pfizer	Completed	No outcome recorded
Phase 3	NCT00644449	Jan 2003 → Mar 2004	chronic bronchitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00643292	Jan 2003 → May 2004	otitis media	Pfizer	Completed	No outcome recorded
Phase 3	NCT00643409	Jan 2003 → Feb 2004	maxillary sinusitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00644293	Jan 2003 → Apr 2004	pharyngitis, tonsillitis	Pfizer	Completed	No outcome recorded
Phase 3	NCT00643227	Jan 2003 → Mar 2004	pneumonia	Pfizer	Completed	No outcome recorded
Phase 3	NCT00229944	Dec 2002 → May 2004	cholera	International Centre for Diarrhoeal Disease Research, Bangladesh	Completed	Met primary
Phase 3	NCT00042718	Nov 2001 → Aug 2003	chronic bronchitis	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Completed	No outcome recorded
Phase 3	NCT00031499	Jun 2000 → Aug 2007	syphilis	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Met primary
Phase 3	NCT00245908	Sep 1999 → Sep 2002	asthma	Wisconsin Research Network	Completed	No outcome recorded
Phase 3	NCT00000617	Sep 1998 → Nov 2005	atherosclerotic cardiovascular disease, coronary artery disorder, myocardial infarction	National Heart, Lung, and Blood Institute (NHLBI)	Completed	No outcome recorded
Phase 3	NCT00002140	—	HIV infectious disease, Mycobacterium avium complex disease	Pfizer	Completed	No outcome recorded
Phase 3	NCT00002122	—	HIV infectious disease, Mycobacterium avium complex disease, fungal infectious disease	Pfizer	Completed	No outcome recorded

Phase 489 trials · 4 met primary · 9 missed
Phase 4	NCT07669207	Aug 2026 → May 2028 expected	preterm premature rupture of the membranes	Alexa Henderson	Recruiting	No outcome recorded
Phase 4	NCT07713186	Aug 2026 → Jan 2027 expected	atopic eczema	Cairo University	Not yet recruiting	No outcome recorded
Phase 4	NCT07608562	Aug 2026 → Jun 2028 expected	cervical incompetence	Wake Forest University Health Sciences	Not yet recruiting	No outcome recorded
Phase 4	NCT07608328	Jun 2026 → Jun 2027 expected	bronchiectasis	Assiut University	Recruiting	No outcome recorded
Phase 4	NCT03523156	Jun 2025 → Apr 2026	trachoma	Emory University	Withdrawn	No outcome recorded
Phase 4	NCT07445282	May → Nov 2025	typhoid fever	Sheikh Zayed Medical College	Completed	No outcome recorded
Phase 4	NCT06917157	May 2025 → May 2026	preterm premature rupture of the membranes	The University of Texas Health Science Center, Houston	Withdrawn	No outcome recorded Stop: Enrollment
Phase 4	NCT06958146	May → Aug 2025 overdue	neonatal sepsis	Armed Forces Hospital, Pakistan	Not yet recruiting	No outcome recorded
Phase 4	NCT07314281	Apr 2025 → Jan 2027 expected	typhoid fever	Indus Hospital and Health Network	Recruiting	No outcome recorded
Phase 4	NCT06010719	Oct 2024 → Jun 2028 expected	protein-energy malnutrition	University of California, San Francisco	Recruiting	No outcome recorded
Phase 4	NCT06349122	Aug 2024 → Mar 2027 expected	bacterial vaginosis	Assistance Publique Hopitaux De Marseille	Not yet recruiting	No outcome recorded
Phase 4	NCT06396078	Jul 2024 → Dec 2026 expected	preterm premature rupture of the membranes	Ohio State University	Recruiting	No outcome recorded
Phase 4	NCT05772013	Mar 2024 → Jun 2028 expected	chronic obstructive pulmonary disease	Dr Ian B Wilkinson	Recruiting	No outcome recorded
Phase 4	NCT04339270	Feb 2023 → Feb 2027 expected	chronic obstructive pulmonary disease	University Hospital, Montpellier	Recruiting	No outcome recorded
Phase 4	NCT05345457	Jan 2023 → Feb 2024	preterm premature rupture of the membranes	University Hospitals Cleveland Medical Center	Terminated	No outcome recorded Stop: Enrollment
Phase 4	NCT05596721	Jan 2023 → Mar 2024	asthma, lung disorder	Second Affiliated Hospital, School of Medicine, Zhejiang University	Unknown	No outcome recorded
Phase 4	NCT05634759	May 2022 → Aug 2023	trachoma	Emory University	Completed	No outcome recorded
Phase 4	NCT03335072	Feb 2022 → Mar 2027 expected	trachoma	University of California, San Francisco	Active not recruiting	No outcome recorded
Phase 4	NCT05132829	Dec 2021 → Dec 2024	cervical incompetence, pregnancy disorder	Thomas Jefferson University	Unknown	Missed primary
Phase 4	NCT04527016	Oct 2021 → Jun 2023	childhood onset asthma	Children's Hospital of Fudan University	Completed	No outcome recorded
Phase 4	NCT04481555	Jun 2021 → Nov 2024	chronic obstructive pulmonary disease, pneumonia	Chronic Obstructive Pulmonary Disease Trial Network, Denmark	Completed	No outcome recorded
Phase 4	NCT05311228	Jun 2021 → Mar 2022	bronchopulmonary dysplasia, intracerebral hemorrhage, necrotizing enterocolitis	Indonesia University	Completed	No outcome recorded
Phase 4	NCT04715295	Oct 2020 → May 2021	COVID-19	Yaounde Central Hospital	Unknown	No outcome recorded
Phase 4	NCT03909737	Sep 2020 → Mar 2025 overdue	—	University of Maryland, Baltimore	Active not recruiting	No outcome recorded
Phase 4	NCT04454151	Aug 2020 → Jan 2022	classic familial adenomatous polyposis	Tel-Aviv Sourasky Medical Center	Unknown	No outcome recorded
Phase 4	NCT04351919	May → Jul 2020	—	Abderrahmane Mami Hospital	Withdrawn	No outcome recorded
Phase 4	NCT04370782	Apr → Sep 2020	COVID-19	St. Francis Hospital, New York	Completed	No outcome recorded
Phase 4	NCT04359316	Apr → May 2020	COVID-19	Shahid Beheshti University of Medical Sciences	Unknown	No outcome recorded
Phase 4	NCT04319705	Mar 2020 → Mar 2022	asthma, chronic obstructive pulmonary disease, immune system disorder	Bispebjerg Hospital	Unknown	No outcome recorded
Phase 4	NCT04171388	Mar 2020 → May 2021	fetal growth restriction, nutritional disorder, sexually transmitted disease, urinary tract infection	Brigham and Women's Hospital	Withdrawn	No outcome recorded
Phase 4	NCT03854929	Dec 2019 → Feb 2021	shigellosis	Oxford University Clinical Research Unit, Vietnam	Completed	No outcome recorded
Phase 4	NCT04047849	Aug 2019 → Jul 2021 overdue	preterm premature rupture of the membranes	Woman's	Recruiting	No outcome recorded
Phase 4	NCT04154722	Jun 2019 → Dec 2020	typhoid fever	Ziauddin University	Completed	No outcome recorded
Phase 4	NCT03608774	Jul 2018 → Feb 2020	chlamydia trachomatis infectious disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Met primary
Phase 4	NCT03490123	Apr 2018 → Apr 2020	yaws	Lihir Medical Centre	Completed	Met primary
Phase 4	NCT03248297	Jan 2018 → May 2020	endometritis, puerperal infection	University of Alabama at Birmingham	Completed	Missed primary
Phase 4	NCT03162497	Jan 2018 → Sep 2022	dry eye syndrome	Medical University of Vienna	Completed	Missed primary
Phase 4	NCT03237182	Jun 2017 → Dec 2022	multidrug-resistant tuberculosis	Centre for the AIDS Programme of Research in South Africa	Terminated	No outcome recorded
Phase 4	NCT02972957	Jan 2017 → Dec 2018	influenza	London School of Hygiene and Tropical Medicine	Completed	Missed primary
Phase 4	NCT03032042	Jan → Feb 2017	helminthiasis	University of California, San Francisco	Withdrawn	No outcome recorded
Phase 4	NCT02775617	Jul 2016 → Aug 2017	impetigo, scabies, yaws	London School of Hygiene and Tropical Medicine	Completed	No outcome recorded
Phase 4	NCT02414399	Jun 2016 → May 2020	coinfection, diarrheal disease, malaria, nutritional disorder +1	University of Washington	Unknown	Missed primary
Phase 4	NCT01903057	Feb → Mar 2014	filariasis, trachoma	Emory University	Withdrawn	No outcome recorded
Phase 4	NCT02003911	Oct 2013 → Jun 2018	asthma	Montefiore Medical Center	Terminated	No outcome recorded Stop: Enrollment
Phase 4	NCT01915082	Sep 2013 → Oct 2015	disease related to solid organ transplantation	Universitaire Ziekenhuizen KU Leuven	Completed	Missed primary
Phase 4	NCT02224040	Aug 2013 → Dec 2014	typhoid fever	Sheba Medical Center	Unknown	Met primary
Phase 4	NCT01779570	Feb 2013 → Apr 2016	influenza	Chinese University of Hong Kong	Completed	No outcome recorded
Phase 4	NCT02575755	Oct 2012 → Jul 2016	Plasmodium falciparum malaria, pregnancy disorder	Papua New Guinea Institute of Medical Research	Unknown	No outcome recorded
Phase 4	NCT01596894	Oct 2012 → Dec 2015	Crohn disease	Prof. Arie Levine	Completed	Missed primary
Phase 4	NCT03485703	Aug 2012 → Apr 2016	bronchopulmonary dysplasia	Hospital de Clinicas de Porto Alegre	Completed	No outcome recorded
Phase 4	NCT02215460	Apr 2012 → Mar 2014	periodontitis	University of Taubate	Completed	No outcome recorded
Phase 4	NCT03045198	Mar 2012 → Dec 2018	cystic fibrosis	University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn)	Unknown	No outcome recorded
Phase 4	NCT01667692	Mar → Nov 2011	Helicobacter pylori infectious disease, dyspepsia, peptic ulcer disease	Shahid Sadoughi University of Medical Sciences and Health Services	Completed	No outcome recorded
Phase 4	NCT01202331	Nov 2010 → Nov 2013	trachoma	University of California, San Francisco	Completed	Mixed
Phase 4	NCT00926796	Jun 2010 → Dec 2012	gonorrhea	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
Phase 4	NCT01109160	Apr 2010 → Oct 2012	transplant-related bronchiolitis obliterans	KU Leuven	Completed	No outcome recorded
Phase 4	NCT01105624	Mar → Nov 2010	dry eye syndrome	Merck Sharp & Dohme LLC	Completed	Met primary
Phase 4	NCT01014078	Oct 2009 → Mar 2010	dry eye syndrome	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00760838	Mar 2009 → Feb 2011	asthma	University Hospital, Ghent	Completed	Missed primary
Phase 4	NCT00411736	May 2008 → Dec 2013	cystic fibrosis	Rigshospitalet, Denmark	Completed	No outcome recorded
Phase 4	NCT00656539	Apr → Nov 2008	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00629590	Mar → Jul 2008	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00629941	Mar → Aug 2008	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00629980	Feb → Sep 2008	blepharitis	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00618449	Jan 2008 → May 2009	trachoma	University of California, San Francisco	Completed	No outcome recorded
Phase 4	NCT00564447	Dec 2007	bacterial infectious disease, eye infectious disorder	Merck Sharp & Dohme LLC	Completed	No outcome recorded
Phase 4	NCT00883818	Jan → Dec 2007	overactive bladder	Samsung Medical Center	Completed	No outcome recorded
Phase 4	NCT00322972	Jun 2006 → Nov 2009	trachoma	University of California, San Francisco	Completed	No outcome recorded
Phase 4	NCT00367120	Jun 2006 → Feb 2007	sinusitis	Pfizer	Completed	No outcome recorded
Phase 4	NCT00471809	Mar 2006 → Mar 2007	asthma	National Heart, Lung, and Blood Institute (NHLBI)	Terminated	Missed primary
Phase 4	NCT00315601	Jan → Nov 2006	—	University of Illinois at Chicago	Terminated	No outcome recorded
Phase 4	NCT00237445	Nov 2005 → Sep 2006	pneumonia	Sanofi	Terminated	No outcome recorded
Phase 4	NCT01009619	Sep 2005 → Dec 2009	bronchiolitis obliterans syndrome, respiratory tract infectious disorder, transplant rejection	KU Leuven	Completed	Mixed
Phase 4	NCT00286026	Jun 2005 → Aug 2007	trachoma	University of California, San Francisco	Withdrawn	No outcome recorded Stop: Enrollment
Phase 4	NCT02600806	May 2005 → Mar 2016	pneumonia	FISABIO Foundation	Unknown	No outcome recorded
Phase 4	NCT00164112	Nov 2004 → Jun 2005	—	Bassett Healthcare	Completed	No outcome recorded
Phase 4	NCT00132951	Oct 2004 → Sep 2006	chronic bronchitis, pneumonia	Sanofi	Terminated	No outcome recorded
Phase 4	NCT07436104	Jan 2004 → Dec 2015	asthma, chronic diarrheal disease, chronic obstructive pulmonary disease, hypertensive disorder +2	MAHAN Trust	Completed	No outcome recorded
Phase 4	NCT00137007	Nov 2003 → Sep 2005	pneumonia	Pfizer	Completed	No outcome recorded
Phase 4	NCT00221364	Mar 2003 → Apr 2005	trachoma	University of California, San Francisco	Completed	No outcome recorded
Phase 4	NCT00643539	Dec 2002 → Jul 2003	tonsillitis	Pfizer	Completed	No outcome recorded
Phase 4	NCT00324818	Jul 2002 → May 2006	bacterial vaginosis	University of Alabama at Birmingham	Completed	No outcome recorded
Phase 4	NCT00359970	Jun 2002 → Aug 2003	diarrheal disease	The University of Texas Health Science Center, Houston	Completed	No outcome recorded
Phase 4	NCT00132860	May 2001 → Dec 2007	chronic obstructive pulmonary disease	Odense University Hospital	Unknown	No outcome recorded
Phase 4	NCT01329588	Mar 2001 → Apr 2002	HIV infectious disease, chlamydia trachomatis infectious disease, gonorrhea	CHU de Quebec-Universite Laval	Completed	No outcome recorded
Phase 4	NCT00035347	Jan 2001 → Jun 2002	pneumonia	Pfizer	Completed	No outcome recorded
Phase 4	NCT00598962	Dec 1994 → Nov 2006	Mycobacterium avium complex disease	The University of Texas Health Science Center at Tyler	Completed	No outcome recorded
Phase 4	NCT00599079	Feb 1993 → May 2008	Mycobacterium avium complex disease	The University of Texas Health Science Center at Tyler	Completed	No outcome recorded
Phase 4	NCT00368342	—	asthma	Baqiyatallah Medical Sciences University	Completed	No outcome recorded

Phase not applicable62 trials · 2 met primary · 4 missed
—	NCT07625228	Jan 2027 → Dec 2030 expected	cardiac valvular defect, heart valve disorder, rheumatic fever	Ladoke Akintola University of Technology, Ogbomoso, Nigeria	Not yet recruiting	No outcome recorded
—	NCT07641348	Jul 2026 → Jan 2027 expected	typhoid fever	Iqra Asghar Ali	Not yet recruiting	No outcome recorded
—	NCT06461429	Nov 2025 → Dec 2050 expected	—	University of Melbourne	Not yet recruiting	No outcome recorded
—	NCT06170983	Jan 2024 → Jan 2026	skin infection	Medical University of Vienna	Unknown	No outcome recorded
—	NCT06077916	Oct 2023 → Aug 2025	—	Clinical Hospital Colentina	Completed	No outcome recorded
—	NCT05842681	Jun 2023 → Jan 2027 expected	idiopathic pulmonary fibrosis	Assiut University	Recruiting	No outcome recorded
—	NCT05647993	Dec 2022 → Nov 2023	—	Department of Medical Services Ministry of Public Health of Thailand	Completed	No outcome recorded
—	NCT05337566	Sep 2022 → Dec 2027 expected	—	Helsinki University Central Hospital	Recruiting	No outcome recorded
—	NCT05328817	May 2022 → May 2025	preterm premature rupture of the membranes	Eastern Virginia Medical School	Unknown	No outcome recorded
—	NCT04374903	Apr 2022	—	King Hussein Cancer Center	Withdrawn	No outcome recorded
—	NCT05016895	Aug 2021 → Jun 2024	—	FHI 360	Completed	No outcome recorded
—	NCT04935515	Apr → May 2021	COVID-19	Manimarane Arjunan, MD,DM (Cardiology)	Completed	No outcome recorded
—	NCT04617626	Nov 2020 → Jan 2021	—	FHI 360	Completed	No outcome recorded
—	NCT03862495	May 2020 → Mar 2024	chlamydia trachomatis infectious disease	University of North Carolina, Chapel Hill	Completed	No outcome recorded
—	NCT04354597	May → Aug 2020	COVID-19	King Hussein Cancer Center	Withdrawn	No outcome recorded
—	NCT04349592	Apr → Aug 2020	COVID-19	Hamad Medical Corporation	Completed	Missed primary
—	NCT04399746	Mar → May 2020	COVID-19	Institute for Social Security and Services for State Workers	Completed	No outcome recorded
—	NCT04202380	Jan 2020 → Jan 2021	preterm premature rupture of the membranes	Assiut University	Completed	Met primary
—	NCT04012177	Jul 2019 → Sep 2022	protein-energy malnutrition	Vital Pakistan Trust	Unknown	No outcome recorded
—	NCT03564652	Aug 2018 → Nov 2020	nutritional deficiency disease	Vital Pakistan Trust	Completed	Mixed
—	NCT03578679	Jul 2018 → Jan 2019	Pediculus humanus capitis infestation	Research Institute for Development	Completed	No outcome recorded
—	NCT03341273	Dec 2017 → Mar 2020	respiratory tract infectious disorder	National Institute of Allergy and Infectious Diseases (NIAID)	Terminated	Missed primary
—	NCT05506371	Sep 2017 → Jun 2019	periodontitis	Ukrainian Medical Stomatological Academy	Completed	No outcome recorded
—	NCT03751514	May 2017 → Feb 2021	pertussis	University of Southampton	Unknown	No outcome recorded
—	NCT03079388	Feb 2017 → Sep 2019	nutritional disorder, pregnancy disorder	Washington University School of Medicine	Completed	No outcome recorded
—	NCT03098485	Jan 2017 → Aug 2022	—	Washington University School of Medicine	Completed	No outcome recorded
—	NCT02830230	Jul 2016 → Dec 2017	—	Tata Memorial Hospital	Unknown	No outcome recorded
—	NCT03629288	Mar → Sep 2016	periodontitis	Universidad Nacional Andres Bello	Completed	Missed primary
—	NCT02544984	Oct 2015 → Mar 2017	lung disorder	The University of Texas Health Science Center, Houston	Completed	Missed primary
—	NCT02336516	Jul 2015 → Apr 2021	Shiga toxin-associated hemolytic uremic syndrome	Assistance Publique - Hôpitaux de Paris	Completed	No outcome recorded
—	NCT02372383	Oct 2014 → Jun 2016	cystic fibrosis	University of Colorado, Denver	Completed	No outcome recorded
—	NCT02491723	Jan 2014 → Jan 2016	bronchiectasis	Shanghai Pulmonary Hospital, Shanghai, China	Completed	No outcome recorded
—	NCT02023554	Dec 2013 → Jul 2014	asthma, chronic obstructive pulmonary disease	Zhujiang Hospital	Completed	No outcome recorded
—	NCT01906450	May → Sep 2013	chronic periodontitis	Universidad del Valle, Colombia	Unknown	No outcome recorded
—	NCT02126267	Jan 2013 → Feb 2014	chronic periodontitis	Centro Universitario de Lavras	Completed	No outcome recorded
—	NCT02622802	Nov 2012 → Dec 2016	pregnancy disorder	University Hospital, Gasthuisberg	Completed	No outcome recorded
—	NCT01618591	Sep 2012 → Mar 2016	dysentery	Uniformed Services University of the Health Sciences	Terminated	No outcome recorded Stop: Enrollment
—	NCT01561703	Mar 2012 → Dec 2013	streptococcal sore throat	University of Missouri-Columbia	Completed	No outcome recorded
—	NCT01560962	Jan → Dec 2012	blepharitis	Southern California Institute for Research and Education	Terminated	No outcome recorded
—	NCT01224977	Jul 2011 → Dec 2018	asthma	Universitaire Ziekenhuizen KU Leuven	Unknown	No outcome recorded
—	NCT01235546	May 2011 → Dec 2015	abscess, endometritis, skin infection	Alan Tita	Completed	Met primary
—	NCT01327625	Mar 2011 → Jun 2013	graft versus host disease, transplant-related bronchiolitis obliterans	Asan Medical Center	Terminated	No outcome recorded
—	NCT01259141	Oct 2010 → Dec 2014	Mycoplasma pneumoniae pneumonia	Capital Medical University	Completed	No outcome recorded
—	NCT01271231	Apr 2010 → Jul 2012	diabetes mellitus, gingivitis, periodontitis	Universidad de Antioquia	Completed	No outcome recorded
—	NCT01586169	Feb 2010	bacterial infectious disease, parasitic infectious disease	Centre d'Appui à la lutte contre la Maladie	Completed	No outcome recorded
—	NCT00805545	Nov 2008 → Nov 2009	infectious disease	University of Florida	Completed	No outcome recorded
—	NCT01178762	Sep → Nov 2007	inclusion conjunctivitis	National Taiwan University Hospital	Completed	No outcome recorded
—	NCT00563251	Apr 2005 → Mar 2007	transplant-related bronchiolitis obliterans	Hospital Authority, Hong Kong	Completed	No outcome recorded
—	NCT00153634	Mar 2004 → Nov 2007	chronic bronchitis, cystic fibrosis	Seattle Children's Hospital	Completed	No outcome recorded
—	NCT00287300	Sep 2003 → Aug 2005	malaria	University of North Carolina	Completed	No outcome recorded
—	NCT00354952	Jul 2002 → Oct 2003	—	University of Antwerp	Completed	No outcome recorded
—	NCT00713999	Aug 2001 → Apr 2002	sexually transmitted disease, urinary schistosomiasis	University of Aarhus	Completed	No outcome recorded
—	NCT00000883	Oct 1997 → Apr 2007	HIV infectious disease, Mycobacterium avium complex disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
—	NCT00002089	—	HIV infectious disease, Mycobacterium avium complex disease	Pfizer	Completed	No outcome recorded
—	NCT00001023	? → Jul 1998	HIV infectious disease, Mycobacterium avium complex disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
—	NCT00000895	? → Aug 2001	HIV infectious disease, Mycobacterium avium complex disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
—	NCT00000947	? → Jul 2000	HIV infectious disease, Mycobacterium avium complex disease	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	No outcome recorded
—	NCT00002082	—	HIV infectious disease, cryptosporidiosis	Pfizer	Completed	No outcome recorded
—	NCT00002309	—	HIV infectious disease, Mycobacterium avium complex disease	Pfizer	Completed	No outcome recorded
—	NCT00002085	—	HIV infectious disease, Mycobacterium avium complex disease, tuberculosis	Pfizer	Completed	No outcome recorded
—	NCT00002328	—	HIV infectious disease, cryptosporidiosis	Pfizer	Completed	No outcome recorded
—	NCT00002090	—	HIV infectious disease, Mycobacterium avium complex disease	Pfizer	Completed	No outcome recorded

Comparator or background therapy198 trials
Phase 0	NCT02099240 Comparator	Mar 2014 → Nov 2018	osteomyelitis	University of Louisville	Terminated	No outcome recorded Stop: Enrollment
Phase 1	NCT06543290 Comparator	Aug 2023 → Aug 2026 overdue	infectious disease	Arrowhead Regional Medical Center	Recruiting	No outcome recorded
Phase 1	NCT04457609 Background	Jul → Aug 2020	COVID-19, pneumonia	Indonesia University	Unknown	No outcome recorded
Phase 1	NCT04280406 Comparator	Feb 2020 → Dec 2023	—	University of Montreal	Unknown	No outcome recorded
Phase 1	NCT05437783 Comparator	Jan 2020 → Jul 2022	—	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Unknown	No outcome recorded
Show all 198 trials opens the full record — a long page

News releases announcing trial results or a regulatory action · 7

Date	Issuer	Release
2024-06-21	BioNet-Asia Co., Ltd.	Regulatory Why are whooping cough infections surging in Australia and should you get a booster jab? bionet-asia.com ↗ The TGA has approved the temporary supply of an overseas-registered product, azithromycin powder, which contains the same quantity of the same active ingredient as Zithromax.
2023-04-10	Zydus Lifesciences Limited	Regulatory Zydus receives final approval from the USFDA for Azithromycin Tablets USP, 500 mg zyduslife.com ↗ Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Azithromycin Tablets USP, 500 mg (USRLD: Zithromax Tablets).
2020-01-01	Alembic Pharmaceuticals Ltd.	Regulatory 28th January, 2020, Vadodara, India alembicpharmaceuticals.com ↗ Alembic Pharmaceuticals Limited (Alembic) today announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Azithromycin Tablets USP, 600 mg.
2020-01-01	Alembic Pharmaceuticals Ltd.	Regulatory 29th January, 2020, Vadodara, India alembicpharmaceuticals.com ↗ Alembic Pharmaceuticals Limited {Alembic) today announced it has received final approvals from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDAs) Azithromycin Tablets USP, 250 mg and 500 mg.
2018-08-01	Zydus Lifesciences Limited	Regulatory Zydus receives final approval from the USFDA for Azithromycin for Oral Suspension USP zyduslife.com ↗ Zydus Cadila has received the final approval from the USFDA to market Azithromycin for Oral Suspension USP (US RLD - Zithromax), 100 mg/5 mL and 200 mg/5 mL.
2016-09-01	Lupin Limited	Regulatory Lupin Receives Tentative Approval for Generic Zithromax® Oral Suspension lupin.com ↗
2005-11-14	Teva Branded Pharmaceutical Products R&D, Inc.	Regulatory Teva Announces Approval of Azithromycin Tablets tevapharm.com ↗ Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDAs for Azithromycin Tablets, 250 mg, 500 mg and 600 mg.

All press releases naming this drug 12 releases

Date	Issuer	Release
2024-06-21	BioNet-Asia Co., Ltd.	Why are whooping cough infections surging in Australia and should you get a booster jab? bionet-asia.com ↗
2023-04-10	Zydus Lifesciences Limited	Zydus receives final approval from the USFDA for Azithromycin Tablets USP, 500 mg zyduslife.com ↗
2020-01-01	Alembic Pharmaceuticals Ltd.	28th January, 2020, Vadodara, India alembicpharmaceuticals.com ↗
2020-01-01	Alembic Pharmaceuticals Ltd.	29th January, 2020, Vadodara, India alembicpharmaceuticals.com ↗
2018-08-01	Zydus Lifesciences Limited	Zydus receives final approval from the USFDA for Azithromycin for Oral Suspension USP zyduslife.com ↗
2018-06-12	Pfizer	Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness pfizer.com ↗
2016-09-01	Lupin Limited	Lupin Receives Tentative Approval for Generic Zithromax® Oral Suspension lupin.com ↗
2015-11-15	Pfizer	Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma pfizer.com ↗
2015-07-24	Knight Therapeutics (USA) Inc	Knight Therapeutics Announces an Exclusive Distribution Agreement for AzaSite(R) in Canada knighttx.com ↗
2006-11-21	Teva Branded Pharmaceutical Products R&D, Inc.	Teva Announces Agreement With Pfizer Regarding Idarubicin, Azithromycin, And Epirubicin tevapharm.com ↗
2006-02-09	Teva Branded Pharmaceutical Products R&D, Inc.	Teva Comments on Pfizer Press Release Regarding Azithromycin tevapharm.com ↗
2005-11-14	Teva Branded Pharmaceutical Products R&D, Inc.	Teva Announces Approval of Azithromycin Tablets tevapharm.com ↗

Evidence & citations 38 cited values

Every value below carries the sentence it was read from. 591 sources stand behind the page.

Field	Value	Cited text
Known as	AZITHROMYCIN	“Bacterial or Viral infection treatment may include: Doxycycline, Minocycline, Nitazoxanide, Hydroxychloroquine, Rifampin, Dapsone, Azithromycin, Tetracycline, Benzathine...” NCT05894954 ↗ 571 “This is a non inferiority test aimed to compare the efficacy and safety in add on to Azithromycin, an antimalarial drug, a treatment combination of the antimalrial drug with an...” NCT04502342 ↗ “Group 2 will receive azithromycin 500 mg once daily (od) (Truxa®, Laboratorios Monte Verde SA, Argentina), levofloxacin 500 mg od (Laboratorios Asofarma de México SA de CV,...” NCT02726269 ↗ “This standard treatment is personalized according to the severity but is not limited to standard antiviral therapy, azithromycin 500 mg a day, vitamin C 500 mg 8 hourly a day,...” NCT05398965 ↗ “Patients receiving azithromycin for prophylaxis or treatment of BOS, must be on a stable regimen for a least 4-weeks prior to randomization and will continue to receive...” NCT03657342 ↗ “Anti-STI regimen: ciprofloxacin 500mg orally, doxycycline 100mg BID orally 7 days and metronidazole 2g orally (cefuroxime im and/or azithromycin alternatively for pregnant and...” NCT00713999 ↗ “azithromycin (Zithromax) pediatric suspension formulation (200 mg/5 ml) administered as an oral suspension at a dose of 20 mg/kg once a day (maximal dose 500 mg/day) for 3...” NCT00643539 ↗ “This randomized add-on open clinical study evaluated the short-term effects of azithromycin (Az) as an adjunct to scaling and root planing (SRP) in patients with chronic periodontitis.” NCT05506371 ↗ “Current guidelines recommend a macrolide-based triple therapy consisting of a macrolide (azithromycin or clarithromycin), ethambutol, and a rifamycin (typically rifabutin).” NCT07585461 ↗ “One of seven antibiotics (amoxicillin; amoxicillin/clavulanate potassium; azithromycin; cefaclor; cephalexin; cefdinir; or clindamycin) will be given at standard dosage” NCT01561703 ↗ “Group 1: Azithromycin 500 mg per day, three days a week plus oral levamisole 150 mg per day, two days a week. Group 2: Azithromycin 500 mg per day, three days a week.” NCT01348321 ↗ Show 561 more sources
Known as	Azasite	“A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical...” NCT00629590 ↗ 8 “Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis” NCT00629980 ↗ “azithromycin (Azasite) ophthalmic solution (1%)” PMID 21138337 ↗ Dec 2010 “AzaSite (azithromycin ophthalmic solution)” NCT00575367 ↗ “1% azithromycin in DuraSite (AzaSite” PMID 17652708 ↗ Aug 2007 NCT01797107 ↗ NCT00656539 ↗ NCT00105534 ↗ NCT00575380 ↗
Known as	AzaSite (azithromycin ophthalmic solution)	“AzaSite (azithromycin ophthalmic solution)” NCT00575380 ↗
Known as	AZI	“The current principle of yaws eradication (the Morges strategy) is based on single round mass drug administration (MDA) of azithromycin (AZI) called total community treatment...” NCT03490123 ↗ 7 “The purpose of this study is to assess the efficacy of 3 days of azithromycin (AZI) compared to 3 days of ciprofloxacin (CIP) (standard-of-care) for the treatment of children...” NCT03854929 ↗ “Azithromycin (AZI) is a macrolide antibiotic but does not have the mentioned druf interactions , has fewer gastrointestinal side effects, and fewer risks of QT prolongation and...” NCT01323582 ↗ “efficacy and safety of azithromycin (AZI) mass drug administration (MDA) to 1-11-month-old infants” PMID 37968741 ↗ Nov 2023 “Azithromycin (AZI) is used for its antibiotic and antimalarial properties in pregnancy.” PMID 26711756 ↗ Dec 2015 “azithromycin (AZI) plus piperaquine (PQ) given as IPTp” NCT02575755 ↗ “Azithromycin (AZI), a broad-spectrum antibiotic” PMID 23629714 ↗ Apr 2013 “azithromycin (AZI) in a malaria-endemic area” PMID 34479861 ↗ Sep 2021
Known as	AZICINE	“Each sachet AZICINE of 1.5 g powder contains: 250mg of Azithromycin dihydrate, dissolved in warm water, dosed to 10mg/kg body weight /daily/ 3 days” NCT03854929 ↗
Known as	AZIT	“combination of two pharmaceutical drugs, Azithromycin (AZIT) and Ivermectin (IVER) administered orally in the treatment of head lice infestations.” NCT03578679 ↗
Known as	Azithro	“Azithromycin (Azithro)” NCT04358068 ↗ 2 “Azithromycin (Azithro)” NCT07625228 ↗ “Azithromycin (Azithro)” NCT07669207 ↗
Known as	Azithromcyin	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07485010 ↗
Known as	Azithromycin Dihydrate	“Zithromax (Azithromycin Dihydrate) 600mg Tablets Pfizer Inc.” NCT00866216 ↗
Known as	Azithromycin Extended Release	“Zmax (Azithromycin Extended Release)” NCT00367120 ↗
Known as	azithromycin immediate release	“azithromycin immediate release (Zithromax)” NCT00644176 ↗
Known as	Azithromycin Injection	“Drug: Azithromycin Injection” NCT06605118 ↗
Known as	Azithromycin monohydrate	“Azithromycin monohydrate is a macrolide antibacterial drug, FDA-approved in the US for the treatment of Chlamydia trachomatis (CT) in dose 1 gram (4 capsules of 250 mg),...” NCT03608774 ↗ 2 “Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals” NCT00866216 ↗ NCT03682640 ↗
Known as	Azithromycin Pfizer	“Azithromycin Pfizer® powder for oral suspension will be used in the active comparator arm” NCT06325293 ↗
Known as	Azithromycin SR	“A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients” NCT00643734 ↗ 1 “Azithromycin SR (Microspheres Formulation)” NCT00254566 ↗
Known as	azithromycin sustained release	“The study was performed to see if a single, 2.0-g oral dose of azithromycin sustained release (SR) was at least as effective as a 7-day regimen of levofloxacin (500 mg once...” NCT00643734 ↗
Known as	Azithromycin Tablets	“Drug: Azithromycin Tablets” NCT04454151 ↗
Known as	Azithromycin/Zithromax	“Azithromycin/Zithromax” NCT01561703 ↗ 1 “Azithromycin=Zithromax” NCT01074554 ↗
Known as	Azithromycine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06349122 ↗ 2 NCT04501965 ↗ NCT04669717 ↗
Known as	AZM	“A single oral dose of azithromycin (AZM) given during labor to women planning a vaginal delivery reduced maternal infections including sepsis, with a stronger effect in...” PMID 41527950 ↗ Jan 2026 6 “AIM: To evaluate the effects of systemic azithromycin (AZM) as an adjunct to scaling and root planing (SRP) in the treatment of generalized chronic periodontitis (ChP).” PMID 21770996 ↗ Jul 2011 “Therefore azithromycin (AZM) is an antibiotic known to have an antiviral effect but also which has anti-inflammatory activity in addition to its antimicrobial effect.” NCT04371107 ↗ “This study was undertaken to prospectively evaluate the effect of long-term azithromycin (AZM) on radiological features in patients with bronchiectasis.” PMID 34974413 ↗ Dec 2021 “administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial” NCT05026749 ↗ “Participants received a once-weekly weight-based dose of 1-5 tablets of azithromycin (AZM: 250mg) or placebo, taken orally.” PMID 35704559 ↗ Jun 2022 “single-dose oral azithromycin (AZM) 20 mg/kg” NCT00356720 ↗
Known as	Azrolid	“combined antibiotic chemotherapy azithromycin(Azrolid) 1 gm single oral dose 2 hours before cesarean delivery” NCT04062175 ↗
Known as	AZT	“This is an exploratory, open label, multi-center study to evaluate the efficacy of hydroxychloroquine (HCQ) (400 mg BID on D1 and 400 mg/day on D2 to D5) and azithromycin (AZT)...” NCT04329572 ↗ 1 “Azithromycin (AZT) placebo o.d.” NCT04358081 ↗
Known as	azythromycin	“By contrast, azythromycin, a bacteriostatic antibiotic of the macrolides family blocking the protein synthesis in bacteria, has a strong inhibitory effect on Stx production and...” NCT02336516 ↗ 3 NCT03474276 ↗ NCT04361461 ↗ NCT01271231 ↗
Known as	COMMON BRAND(S): Zithromax GENERIC NAME(S): Azithromycin	“COMMON BRAND(S): Zithromax GENERIC NAME(S): Azithromycin” NCT04341727 ↗
Known as	CP-62,993	“azithromycin SR (Zithromax; compound: CP-62,993)” NCT00643409 ↗ 1 “azithromycin SR (Zithromax; compound: CP-62,993)” NCT00644449 ↗
Known as	SHB001	“SHB001, an azithromycin dermal formulation” NCT01243008 ↗
Known as	T1225	“Azithromycin (T1225)” NCT00357383 ↗ 3 “Azithromycin (T1225)” NCT00357773 ↗ “Azithromycin (T1225)” NCT00357292 ↗ “Azithromycin (T1225)” NCT00357539 ↗
Known as	Xithrone	“Azithromycin 1Gm orally, single dose (Xithrone 500 mg two tablets, Amoun, Inc, Cairo, Egypt) Group (A) OR” NCT03233880 ↗ 1 “nebulized azithromycin (Xithrone, Amoun, Egypt)” NCT06584474 ↗
Known as	Zithromax	“Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Geneva 600 mg Azithromycin Monohydrate Tablets and Pfizer Inc. (Zithromax) 600 mg Azithromycin...” NCT00865670 ↗ 24 “Participants will use azithromycin (Zithromax) 500mg three times a week (10mg.kg for participants under 50Kg) which can be dropped to 250 mg three times a week for dose related...” NCT06272370 ↗ “azithromycin (Zithromax) pediatric suspension formulation (200 mg/5 ml) administered as an oral suspension at a dose of 20 mg/kg once a day (maximal dose 500 mg/day) for 3...” NCT00643539 ↗ “The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP.” NCT00137007 ↗ “Zithromax® for oral suspension is supplied in bottles containing azithromycin dehydrate powder equivalent to 1200mg per bottle” NCT03676751 ↗ “ZITHROMAX ® 40mg/ml solution. DCI : Azithromycin . Pfizer ® 20mg/kg dose with a maximum dose of 500mg per day for three days” NCT02336516 ↗ “treated with either Ketek® Telithromycin Once Daily for 7 Days, or Zithromax® Azithromycin Once Daily for 5 Days” NCT00237445 ↗ “azithromycin (Zithromax®) was donated by Pfizer via the International Trachoma Initiative (ITI).” PMID 37152362 ↗ Apr 2023 “Azithromycin capsule (Zithromax, Pfizer) (250 mg / 12hrs on empty stomach for 3 days)(Group 1).” NCT05118984 ↗ “Group 1 of 15 subjects: 2 g AZ (Zithromax) plus 300 mg CQ base weekly for 6 weeks” NCT03278808 ↗ “Exploratory study of a novel "oleogel" dosage form of Azithromycin (Zithromax)” NCT05796362 ↗ Show 14 more sources
Known as	Zithromax (Zimexir, Exir, Brojerd, Iran)	“Zithromax (Zimexir, Exir, Brojerd, Iran)” NCT01921738 ↗
Known as	Zithromax	“Zithromax (azithromycin) 500mg tablets” NCT00232154 ↗
Known as	Zitromax (Azithromycin Dihydrate, Pfizer, ZTM250)	“Zitromax (Azithromycin Dihydrate, Pfizer, ZTM250)” NCT01009619 ↗
Known as	Zmax	“Azithromycin, also known as Zithromax or Zmax or Zpak” NCT04374552 ↗ 1 “Zmax (Azithromycin Extended Release)” NCT00367120 ↗
Known as	Zpak	“Azithromycin, also known as Zithromax or Zmax or Zpak” NCT04374552 ↗
Action	Inhibit	“the ability of azithromycin to inhibit alginate-production” NCT00411736 ↗
Modality	Small molecule	“macrolide antibiotics” NCT00001023 ↗
Route	Oral	“600 milligrams orally once a week” NCT00000617 ↗
Target	CYP3A4	“Azithromycin is a possible weak to moderate inhibitor of CYP3A4” NCT00983294 ↗